Based on initial observations from Fig. 2B, in which a subset of CRPC-Ad samples displayed increased gene expression for MYBL2, we extended this analysis to samples from patients with adenocarcinoma in TCGA (Fig. 4D) and SU2C (Fig. 4E) datasets. The gene discussed is MYBL2; the disease is adenocarcinoma.